vimarsana.com

Page 2 - Numeric Rating Scale News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Discussing New Phase 2 Findings on Lutikizumab for Hidradenitis Suppurativa with Alexa Kimball, MD, MPH

Kimball discusses her team’s new late-breaking data regarding the safety and effectiveness of lutikizumab in treating the symptoms of moderate-to-severe HS in adult non-responders to anti-TNF therapy.

United statesAlexa kimballHarvard medical schoolAmerican academy of dermatologyAnnual meetingHidradenitis suppurativa clinical responseMassachusetts general hospitalNumeric rating scaleGlobal assessmentHidradenitis suppurativaAnti tnfPhase 2Late breaking

Upadacitinib Effective in Treating Patients With Moderate to Severe AD, Study Says

Adult patients with moderate to severe atopic dermatitis (AD) had a 1-year and 1.5-year upadacitinib drug survival of 91.5% and 80.2%, respectively.

European medicines agencyJanus kinaseImage creditEczema areaSeverity indexNumeric rating scaleDermatology life quality indexAtopic dermatitisDrug survival

Endometriosis: Pain Catastrophizing Tied to Pain Disability

In endometriosis, pain catastrophizing significantly affects pain disability, and vice versa, according to new research.

Medstar washington hospital centerDistrict of columbiaUnited statesCarolinef pukallJames robinsonQueens universityPain catastrophizing scalePain disability indexMedscape medicalNumeric rating scaleHolistic multidisciplinaryMedscape medical newsPain managementAbdominal painAcute painGynecologic pain gynaecologic

Positive Response Observed in HS Patients Having Failed Anti-TNF Therapy Treated with Lutikizumab

These phase 2 data on hidradenitis suppurativa patients highlight new information on the use of lutikizumab as a treatment alternative.

Alexab kimballRoopal thakkarHarvard medical schoolBeth israel deaconess medical centerNumeric rating scaleHidradenitis suppurativaTnf therapy

Procedural sedation and analgesia versus general anesthesia for hysteroscopic myomectomy (PROSECCO trial): A multicenter randomized controlled trial

Julia van der Meulen and co-workers compare procedural sedation and analgesia versus general anesthesia in women undergoing hysteroscopic myomectomy for fibroids.

United statesNoord brabantUnited kingdomEteläuomen läiJennye myersGynaecologie nederlandAmerican society of anesthesiologistsResearch in obstetricsCentre in veldhovenDutch gynecologic patient organizationHealth researchInternational federation of gynecologyUniversity of manchesterDutch consortium for healthcare evaluationDevelopment zonAmerican society

vimarsana © 2020. All Rights Reserved.